Skip to content
healthcare.dev

Lamotrigine

NDC 42291-447, Lamotrigine, tablet, film coated, extended release, from AvKARE.

Product NDC
42291-447
Status
Listed
Labeler
AvKARE
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207497
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42291-447 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE250 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
42291-447-304229104473030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42291-447-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a63e19c0-a093-e896-e053-2a95a90a7ccd

Use it

Look up 42291-447 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42291-447 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42291-447. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.